Floatz logo

209 assets in Breast Carcinoma

Therapeutic assets addressing Breast Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Trastuzumab
Breast Carcinoma
SWOG Cancer Research NetworkP4BBB (76)
Pertuzumab
Breast Carcinoma
SWOG Cancer Research NetworkP3BBB (75)
Tamoxifen
Breast Carcinoma
Dartmouth-Hitchcock Medical CenterP4BBB (75)
Trastuzumab Deruxtecan
Breast Carcinoma
SWOG Cancer Research NetworkP4BBB (75)
Zoledronate
Breast Carcinoma
Washington University School of MedicineP4BBB (75)
Cyclophosphamide
Breast Carcinoma
UNC Lineberger Comprehensive Cancer CenterP3BBB (74)
Dexasone
Breast Carcinoma
Tianjin Medical University Cancer Institute and HospitalP4BBB (73)
Letrozole
Breast Carcinoma
OHSU Knight Cancer InstituteP4BBB (73)
Olaparib
Breast Carcinoma
The Netherlands Cancer InstituteP4BBB (73)
Adriamycin
Breast Carcinoma
Tanta UniversityP3BBB (72)
Carboplatin
Breast Carcinoma
RenJi HospitalP3BBB (72)
Exemestane
Breast Carcinoma
Dartmouth-Hitchcock Medical CenterP4BBB (72)
Anastrozole
Breast Carcinoma
Dartmouth-Hitchcock Medical CenterP4BB (71)
Docetaxel
Breast Carcinoma
Dana-Farber Cancer InstituteP3BB (71)
Cediranib
Breast Carcinoma
M.D. Anderson Cancer CenterP2BB (70)
Denosumab
Breast Carcinoma
Washington University School of MedicineP3BB (70)
Irinotecan
Breast Carcinoma
OHSU Knight Cancer InstituteP3BB (70)
Palbociclib
Breast Carcinoma
Hongmei Zheng, PhDP4BB (70)
Pyrotinib
Breast Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityP3BB (70)
Aspirin
Breast Carcinoma
Mayo ClinicP3BB (69)
Atezolizumab
Breast Carcinoma
Dana-Farber Cancer InstituteP3BB (68)
Enzalutamide
Breast Carcinoma
Nuvation Bio Inc.P2BB (68)
Epirubicin
Breast Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityP3BB (68)
Fludeoxyglucose
Breast Carcinoma
University of WashingtonP2BB (68)
Sargramostim
Breast Carcinoma
Mayo ClinicP3BB (68)
Vitamin D
Breast Carcinoma
Tanta UniversityP2BB (68)
Eribulin Monomethanesulfonate
Breast Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityP3BB (67)
Fulvestrant
Breast Carcinoma
IDEAYA BiosciencesP3BB (67)
Niraparib
Breast Carcinoma
OHSU Knight Cancer InstituteP3BB (67)
Rituximab
Breast Carcinoma
National Cancer Institute (NCI)P2BB (67)
Tucatinib
Breast Carcinoma
Dana-Farber Cancer InstituteP3BB (67)
Veliparib
Breast Carcinoma
National Cancer Institute (NCI)P2BB (67)
Capecitabine
Breast Carcinoma
University Health Network, TorontoP3BB (66)
Cis-Diamminedichloroplatinum Ii
Breast Carcinoma
National Cancer Institute (NCI)P3BB (66)
Elacestrant
Breast Carcinoma
Kristina A. FanucciP3BB (66)
Famitinib
Breast Carcinoma
Fudan UniversityP3BB (66)
Pazopanib
Breast Carcinoma
University Medical Center GroningenP4BB (66)
Trastuzumab Emtansine
Breast Carcinoma
SWOG Cancer Research NetworkP3BB (66)
Everolimus
Breast Carcinoma
UNC Lineberger Comprehensive Cancer CenterP3BB (65)
Huaier Granule
Breast Carcinoma
Fudan UniversityP4BB (65)
Lenvatinib
Breast Carcinoma
University Medical Center GroningenP4BB (65)
Megestrol Acetate
Breast Carcinoma
Tianjin Medical University Cancer Institute and HospitalP4BB (65)
Neratinib
Breast Carcinoma
Fudan UniversityP2BB (65)
Pembrolizumab
Breast Carcinoma
The Netherlands Cancer InstituteP3BB (65)
Toremifene
Breast Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityP4BB (65)
Calcium
Breast Carcinoma
Benha UniversityP2BB (64)
Eribulin
Breast Carcinoma
Sun Yat-sen UniversityP3BB (64)
Indocyanine Green
Breast Carcinoma
City of Hope Medical CenterP3BB (64)
Zanidatamab
Breast Carcinoma
QuantumLeap Healthcare CollaborativeP2BB (64)
Alpelisib
Breast Carcinoma
OHSU Knight Cancer InstituteP2B (63)
Showing 1 to 50 of 209 assets
PreviousPage 1 of 5Next